Doliver Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.58M | Sell |
10,159
-79
| -0.8% | -$18.4K | 0.58% | 25 |
|
|
2026
Q1 | $2.5M | Sell |
10,238
-616
| -6% | -$143K | 0.57% | 20 |
|
|
2025
Q4 | $2.25M | Sell |
10,854
-1,147
| -10% | -$227K | 0.56% | 25 |
|
|
2025
Q3 | $2.23M | Sell |
12,001
-1,635
| -12% | -$280K | 0.58% | 26 |
|
|
2025
Q2 | $2.08M | Sell |
13,636
-555
| -4% | -$85.3K | 0.57% | 30 |
|
|
2025
Q1 | $2.35M | Buy |
14,191
+192
| +1% | +$30K | 0.66% | 20 |
|
|
2024
Q4 | $2.02M | Sell |
13,999
-292
| -2% | -$45.2K | 0.56% | 26 |
|
|
2024
Q3 | $2.32M | Buy |
14,291
+61
| +0.4% | +$9.72K | 0.64% | 21 |
|
|
2024
Q2 | $2.08M | Sell |
14,230
-900
| -6% | -$134K | 0.58% | 21 |
|
|
2024
Q1 | $2.39M | Sell |
15,130
-267
| -2% | -$42.5K | 0.67% | 17 |
|
|
2023
Q4 | $2.41M | Sell |
15,397
-672
| -4% | -$103K | 0.74% | 16 |
|
|
2023
Q3 | $2.5M | Sell |
16,069
-54
| -0.3% | -$8.91K | 0.75% | 16 |
|
|
2023
Q2 | $2.67M | Sell |
16,123
-278
| -2% | -$44.9K | 0.81% | 14 |
|
|
2023
Q1 | $2.54M | Buy |
16,401
+2,349
| +17% | +$379K | 0.8% | 15 |
|
|
2022
Q4 | $2.48M | Sell |
14,052
-135
| -1% | -$23.3K | 0.82% | 13 |
|
|
2022
Q3 | $2.32M | Sell |
14,187
-12
| -0.1% | -$2.03K | 0.86% | 13 |
|
|
2022
Q2 | $2.52M | Buy |
14,199
+4,540
| +47% | +$809K | 0.9% | 14 |
|
|
2022
Q1 | $1.71M | Hold |
9,659
| – | – | 0.54% | 27 |
|
|
2021
Q4 | $1.66M | Sell |
9,659
-417
| -4% | -$68.3K | 0.52% | 29 |
|
|
2021
Q3 | $1.63M | Sell |
10,076
-174
| -2% | -$29.7K | 0.55% | 29 |
|
|
2021
Q2 | $1.69M | Buy |
10,250
+297
| +3% | +$49.2K | 0.56% | 24 |
|
|
2021
Q1 | $1.64M | Buy |
9,953
+233
| +2% | +$37.7K | 0.61% | 28 |
|
|
2020
Q4 | $1.53M | Buy |
9,720
+900
| +10% | +$133K | 0.68% | 28 |
|
|
2020
Q3 | $1.31M | Buy |
8,820
+85
| +1% | +$12.6K | 0.67% | 27 |
|
|
2020
Q2 | $1.23M | Buy |
8,735
+380
| +5% | +$55.4K | 0.55% | 36 |
|
|
2020
Q1 | $1.29M | Sell |
8,355
-604
| -7% | -$85.7K | 0.64% | 31 |
|
|
2019
Q4 | $1.31M | Sell |
8,959
-635
| -7% | -$86.1K | 0.52% | 30 |
|
|
2019
Q3 | $1.27M | Buy |
9,594
+465
| +5% | +$61.3K | 0.51% | 30 |
|
|
2019
Q2 | $1.27M | Buy |
9,129
+67
| +0.7% | +$9.27K | 0.5% | 25 |
|
|
2019
Q1 | $1.27M | Buy |
9,062
+121
| +1% | +$16.2K | 0.51% | 22 |
|
|
2018
Q4 | $1.15M | Sell |
8,941
-1,545
| -15% | -$216K | 0.57% | 17 |
|
|
2018
Q3 | $1.45M | Buy |
10,486
+172
| +2% | +$22.9K | 0.6% | 14 |
|
|
2018
Q2 | $1.25M | Buy |
10,314
+358
| +4% | +$44.7K | 0.52% | 18 |
|
|
2018
Q1 | $1.28M | Buy |
9,956
+2,760
| +38% | +$373K | 0.56% | 13 |
|
|
2017
Q4 | $1M | Sell |
7,196
-655
| -8% | -$91.2K | 0.4% | 34 |
|
|
2017
Q3 | $1.02M | Buy |
7,851
+647
| +9% | +$85.8K | 0.46% | 44 |
|
|
2017
Q2 | $953K | Buy |
+7,204
| New | +$919K | 0.46% | 41 |
|
Other funds holding JNJ
Doliver Advisors's JNJ Position: Q2 2026 in Review
Doliver Advisors reduced its Johnson & Johnson (JNJ) stake by 0.77% in Q2 2026, selling an estimated $18.4K and leaving 10,159 shares worth $2.58M. The position accounts for 0.58% of the portfolio, ranked #25.
Doliver Advisors first reported a position in JNJ in Q2 2017 and has held it in 37 quarters since. The position peaked at $2.67M in Q2 2023. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Doliver Advisors held 10,159 shares of Johnson & Johnson worth $2.58M as of Q2 2026.
- Doliver Advisors sold 79 Johnson & Johnson shares in Q2 2026, an estimated $18.4K.
- Johnson & Johnson made up 0.58% of Doliver Advisors's portfolio in Q2 2026, its #25 holding.
- Doliver Advisors first reported a position in Johnson & Johnson in Q2 2017 and has held it in 37 quarters since.
- Doliver Advisors's Johnson & Johnson position peaked at $2.67M in Q2 2023.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Doliver Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.